On the other hand, Ho et al. demonstrate that treatment of breast cancer cells with doxorubicin generates an NF-κB complex that is deficient in both phosphorylation and acetylation and represses anti-apoptotic gene transcription in a mechanism independent of histone deacetylases [12]. Here, NFKB1 is linked to breast cancer.